| Pharmaceutical active ingredients: |
| ClioquinolHydrocortisonePramoxine Hydrochloride |
| Available forms, composition and doses of 1 + 1 F: |
| Cream; Topical; Clioquinol 3%; Hydrocortisone 1%; Pramoxine Hydrochloride 1% |
| 1 + 1 F medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07CA01 - Hydrocortisone and antibioticsP01AA52 - Clioquinol, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Dunhall Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vioformo-Cort | Clioquinol; Hydrocortisone | Novartis |
| Antiblef Eczem | Clioquinol; Hydrocortisone Acetate | Novartis |
| Barquinol HC | Clioquinol; Hydrocortisone Acetate | Sanofi-Aventis |
| Cortoquinol | Clioquinol; Hydrocortisone Acetate | East India Pharmaceutical Works |
| Hydroderm-C | Clioquinol; Hydrocortisone Acetate | Integrated Contract Manufacturing |
| Ictioformica | Clioquinol; Ichthammol; Triamcinolone Acetonide | Alcon |
| Suyodil | Clioquinol; Kaolin; Pectin | Farmacos Continentales |
| Compound Clioquinol Topical Powder | Clioquinol; Lactic Acid; Lactose; Zinc Stearate | Unidentified Pharmaceutical Company |
| Polyderm | Clioquinol; Mesulfen; Prednisolone; Salicylic Acid | Chowgule |
| Flamin 400 | Clioquinol; Metronidazole | Loren Laboratorios Farmaceuticos |